4-[3-Difluoromethyl-5-(3-fluoro-4-methoxy-phenyl)-pyrazol-1-yl]benzenesulfonamide

Deracoxib (CAS 169590-41-4) is a high-purity reference standard produced and distributed by WITEGA Laboratorien Berlin-Adlershof GmbH. This COX-2 inhibitor reference material supports LC-MS/MS and GC-MS quantification with traceable calibration and robust method validation. It performs reliably in veterinary matrices and complex samples. Moreover, it fits multi-residue method development in regulated laboratories and pharmaceutical research, ensuring confident confirmatory analysis and consistent results.

Designed for accuracy, this reference standard helps you build reliable calibration curves and quality controls. Furthermore, it streamlines workflow setup and speeds up validation.

• High chemical purity and verified identity for dependable results.
• Traceable lot documentation with detailed CoA to support audits.
• Optimized for LC-MS/MS and GC-MS across diverse matrices.
• Proven stability to support long-term monitoring plans.
• Clear handling guidance to simplify routine preparation.

Use it confidently across critical analytical tasks:

• Residue control and surveillance in veterinary and feed testing.
• Calibration, recovery studies, and precision assessments.
• Confirmatory analysis in regulatory workflows.
• Pharmaceutical research and metabolism studies.
• Multi-residue method development and screening.

For best performance, prepare fresh working solutions and follow your validated procedures. Therefore, you achieve linear response, low measurement uncertainty, and reproducible quantification. Choose Deracoxib (CAS 169590-41-4) from WITEGA Laboratorien Berlin-Adlershof GmbH to secure traceable calibration, rigorous method validation, and confident confirmatory analysis in LC-MS/MS or GC-MS.

You can download your Safety Data Sheet for NS047

For other languages please contact us: witega@witega.de